Vehar; Gordon A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vehar; Gordon A..The latest application filed is for "method and therapeutic compositions for the treatment of myocardial infarction".

Company Profile

0.20.1

Vehar; Gordon A. - San Carlos CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Human tPA production using vectors coding for DHFR protein Grant H2,181 - Levinson , et al. February 6, 2	2007-02-06
Methods and Deoxyribonucleic acid for the preparation of tissue factor protein Grant 7,084,251 - Lawn , et al. August 1, 2	2006-08-01
Methods and deoxyribonucleic acid for the preparation of tissue factor protein Grant 7,049,131 - Lawn , et al. May 23, 2	2006-05-23
Methods and deoxyribonucleic acid for the preparation of tissue factor protein Grant 6,994,988 - Lawn , et al. February 7, 2	2006-02-07
Methods for the treatment of coagulation disorders with lipoprotein associated coagulation inhibitor (LACI) Grant 6,986,894 - O'Brien , et al. January 17, 2	2006-01-17
Method and therapeutic compositions for the treatment of myocardial infarction App 20030206904 - O'Brien, Donogh P. ; et al.	2003-11-06
Human tissue plasminogen activator Grant 5,753,486 - Goeddel , et al. May 19, 1	1998-05-19
Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders Grant 5,739,101 - Roy , et al. April 14, 1	1998-04-14
Vectors and cell lines capable of correctly splicing exon regions Grant 5,683,905 - Capon , et al. November 4, 1	1997-11-04
Preparation of functional human factor VIII and pharmaceutical treatment therewith Grant 5,668,108 - Capon , et al. September 16, 1	1997-09-16
Preparation of functional human factor VIII and pharmaceutical treatment therewith Grant 5,618,788 - Capon , et al. April 8, 1	1997-04-08
Functional human factor VIII Grant 5,618,789 - Capon , et al. April 8, 1	1997-04-08
Method and therapeutic compositions for the treatment of myocardial infarction Grant 5,589,173 - O'Brien , et al. December 31, 1	1996-12-31
DNA encoding tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders Grant 5,589,363 - Roy , et al. December 31, 1	1996-12-31
Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders Grant 5,346,991 - Roy , et al. September 13, 1	1994-09-13
Protease resistant urokinase Grant 5,219,569 - Blaber , et al. June 15, 1	1993-06-15
Truncated human tissue plasminogen activator Grant 5,185,259 - Goeddel , et al. February 9, 1	1993-02-09
Preparation of functional human urokinase proteins Grant 5,112,755 - Heyneker , et al. May 12, 1	1992-05-12
Treatment of bleeding disorders using lipid-free tissue factor protein Grant 5,017,556 - O'Brien , et al. May 21, 1	1991-05-21
Preparation of functional human factor VIII in mammalian cells using methotrexate based selection Grant 4,965,199 - Capon , et al. October 23, 1	1990-10-23
Human tissue plasminogen activator Grant 4,766,075 - Goeddel , et al. August 23, 1	1988-08-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.